在早期肺癌进展中,CD47介导的免疫逃避
Cheng-Hao Chuang1, Yen-Yi Zhen2, Juei-Yang Ma1
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
在细胞外囊泡中发现的可溶性CD47在早期肺癌中升高,使先天免疫力失活,促进瘤进展. 这个免疫检查点是肺癌发展的关键病理效应因子.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 巨细胞对肺免疫非常重要.
- CD47 (免疫检查点) 通过SIRPα相互作用抑制巨细胞功能.
- 在癌症中,CD47促进免疫逃避.
研究的目的:
- 研究CD47在肺癌进展中的作用.
- 确定CD47是否存在于细胞外囊泡中.
- 评估细胞外囊泡CD47在早期肺癌中的临床意义.
主要方法:
- 在肺癌细胞系和患者血中分析了CD47表达.
- 在早期肺癌患者中量化了细胞外囊泡CD47水平.
- 建立了一个正管异种移植模型来模仿肺癌.
- 在模型中测量了血清可溶性CD47和细胞因子比率 (IL-10/TNF-α).
主要成果:
- CD47高度集中在来自肺癌细胞和患者血的细胞外囊中.
- 细胞外囊泡CD47在早期肺癌患者中显著高.
- 异种移植模型显示了血清溶解CD47的增加和IL-10/TNF-α比率的升高.
- CD47表达与瘤透巨细胞的减少和瘤相关巨细胞的增加相关.
结论:
- CD47是早期肺癌进展的关键因素.
- 细胞外囊泡CD47有助于天生的免疫失活.
- 溶性CD47在肺癌中起到关键的病理效应作用.
更多相关视频
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy
